Fosamax Lawsuit

On February 8, 2012, research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (“AAOS”) concluded that patients who suffer a Fosamax thigh fracture while taking bisphosphonates such as Fosamax, Boniva, Reclast and Actonel can decrease their risk of suffering f...

PRESS RELEASE: Bernstein Liebhard LLP reports that on February 3, 2012, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) ordered that all Fosamax lawsuits filed in federal court by individuals alleging that they sustained an atypical femur fracture as a result of taking the bispho...

PRESS RELEASE: Bernstein Liebhard LLP reports on a new study published in The New England Journal of Medicine, concluding that bone loss and osteoporosis develop so slowly that women who have normal bone density at age 65 can wait 15 years before undergoing a second bone density test.  As report...

PRESS RELEASE: Bernstein Liebhard LLP reports that the Honorable Carol E. Higbee, who is overseeing the consolidated Fosamax lawsuits, In re: Fosamax Litigation (No. 282 NJ. Super. Ct.) pending in the Superior Court of New Jersey, Atlantic County, issued a Case Management Order regarding four Fo...

PRESS RELEASE: On September 8, 2011, two advisory panels to the U.S. Food and Drug Administration* (“FDA”) convened to discuss the safety of bisphosphonates such as Fosamax, which are used in the treatment of osteoporosis.  Although the participants declined to make a recommendation as to wh...

On September 8, 2011, opening statements in Secrest v. Merck, a Fosamax lawsuit that is part of the consolidated litigation, In re Fosamax Products Liability Litigation, took place.  Pending in the U.S. District Court for the Southern District of New York, this bellwether Fosamax lawsuit is before ...

PRESS RELEASE: On September 8, 2011, opening statements in Secrest v. Merck, a  Fosamax lawsuit that is part of the consolidated litigation, In re Fosamax Products Liability Litigation (“MDL No. 1789”), took place.  The bellwether Fosamax lawsuit is pending in the U.S. District Court for th...

On September 7, 2011, Secrest v. Merck, the fifth Fosamax lawsuit in In re Fosamax Products Liability Litigation began in the U.S. District Court for the Southern District of New York.  This Fosamax lawsuit is part of a consolidated multidistrict litigation pending before Judge John F. Keenan.  Th...

The Fosamax femur fracture lawsuits currently pending before Judge Carol E. Higbee in the Superior Court of New Jersey, Atlantic County are progressing.  Recently, Judge Carol E. Higbee, who is presiding over the consolidated Fosamax femur fracture lawsuits, established a tentative plan of action, ...

The U.S. Food and Drug Administration (“FDA”) announced that an advisory committee will meet on September 9, 2011 to review whether long-term bisphosphonate use puts patients at an increased risk for sustaining atypical femur fractures and osteonecrosis of the jaw (“ONJ”).  Given that an es...